Although the heart contains lysosomes, it has been uncertain whether these organelles and their proteolytic enzymes can play an important role in cardiac protein degradation. Recent studies have demonstrated that fetal mouse hearts in organ culture sustain selective derangements in lysosomal structure and function during exposure to chloroquine or nonmetabolizable sugars. Accordingly, we tested the effects of these agents on cardiac proteolysis under controlled conditions in vitro using two techniques (measurement of loss of radioactivity from trichloroacetic add-precipitable protein after prelabeling with tritiated phenylalanine and measurement of loss of cold phenylalanine after blockade of protein synthesis with cycloheximide). Chloroquine (0.1 D M ) reduced the average rate of protein breakdown in hearts of matched littermates from 45%/24 hours to 32%/24 hours (P < 0.01) and decreased the release of cold phenylalanine by 31 ± 5%(0.108 vs. 0.075 nmol/mg per hour, P < 0.01). Exposure to 100 DIM sucrose for 24-48 hours reduced the rate of breakdown from 44%/24 hours to 33%/24 hours (P < 0.01) and decreased the release of cold phenylalanine by 35 ± 9% (0.092 vs. 0.060 nmol/mg per hour, P < 0.01). The results suggest that interference with lysosomal function in cultured fetal mouse hearts causes a significant reduction in the cardiac capacity to degrade proteins.
ALTHOUGH the myocardium is known to contain lysosomes, it has been uncertain whether these organelles and their proteolytic enzymes play an important role in regulating cardiac protein degradation. 1 One approach which might help to resolve this issue would be to determine whether experimental interference with normal lysosomal properties alters the rate of proteolysis.
One problem in adopting such an approach is to select a suitable experimental model. Agents that cause selective lysosomal derangements, if given in vivo, might cause systemic noncardiac effects which could confuse the interpretation of their specific myocardial actions. Therefore, we chose to use isolated hearts in vitro. Because the effects on lysosomal function might be slow to develop, we chose to use an in vitro model which can function stably for many hours to days, i.e., the fetal mouse heart in organ culture. 2 A second problem in approaching this question is to choose appropriate agents to interfere selectively with lysosomal function while causing minimal primary abnormalities in other cellular systems. This problem is made more difficult by the fact that many of the agents which might otherwise be suitable, such as some specific inhibitors of individual lysosomal proteolytic enzymes, cannot readily cross cell membranes and gain access to the lysosomes. Recently, however, two types of agents-nonmetabolizable sugars and chloroquine -have been identi-fied which become concentrated in lysosomes of living cells and which produce severe lysosomal dysfunction without causing major abnormalities in other organelles. 3 " 13 Like many other tissues, fetal mouse hearts in organ culture react to these agents by developing striking, selective lysosomal abnormalities. 14 ' l5 Exposure to chloroquine causes the rapid development of bizarre lysosomes with myelin figures and inclusion bodies: 14 at the same time, the lysosomal pH becomes alkaline (higher than optimal for most lysosomal hydrolases), and the drug produces a direc.t biochemical inhibition of at least one lysosomal proteinase, cathepsin B,. 11 Nonmetabolizable sugars such as sucrose are conventionally viewed as being confined to the extracellular space. This is true only in the short term, however, and over a period of many hours the sugars are slowly taken into cells by endocytosis and progressively stored in lysosomes. 3 " 5 During exposure to sucrose for 24-48 hours, lysosomes of fetal mouse hearts in organ culture sequester large amounts of the sugar and swell into giant vacuoles; these vacuoles seem unable to maintain the acid pH required for effective activity of most of the lysosomal enzymes, and many inclusion particles are accumulated. 15 Accordingly, since chloroquine and sucrose provide means to produce selective cardiac lysosomal derangements under precisely controlled conditions in vitro, we undertook studies to test their simultaneous effects on cardiac protein degradation.
Methods

Culture Conditions
As described in detail previously, 2 hearts were removed aseptically from 18-to 20-day fetal mice (Charles River, albino outbred), washed gently, and placed on stainless steel grids at a liquid-oxygen interface in shallow culture dishes. Hearts of this age weigh 2-5 mg and measure 0.5-2 mm in their major diameters. The hearts beat rhythmically and maintain stable metabolic characteristics for several days under appropriate culture conditions . 2t l6
Control hearts were maintained in 50% Earle's salt solution (Grand Island Biological Co.) plus 50% fetal calf serum (Colorado Serum Co.) supplemented with insulin, 50 /J.g/ml (Schwarz/Mann). Experimental hearts from matched littermates were maintained in identical media to which had been added 100 mM sucrose, 100 mM urea, or 0.1 mM chloroquine. Previous studies had established that these concentrations induce major lysosomal alterations without altering the contractile ability of the hearts or producing major abnormalities in other organelles. 14 ' 15 In some experiments, cycloheximide (Sigma) was added to control and experimental media at a concentration of 2.5 /ng/ml, a level that, in this system, inhibits incorporation of radioactive amino acid into protein by >90%. 17 For studies requiring the use of radioactive amino acids, cultures were exposed to 10 /iCi/ml of L-[side chain-2,3-3 H]phenylalanine (50 Ci/mmol; Schwarz/Mann) plus nonradioactive carrier, 16 /ng/ml. For studies of protein degradation, the hearts were transferred to medium lacking radioactive amino acids and containing excessive concentrations (500 /ng/ml) of unlabeled phenylalanine to minimize reutilization of previously incorporated label.
Biochemical Analyses
Analyses were performed on the heart tissue and on the culture medium after cultivation under various conditions for 1-2 days. Total protein content of each heart was determined by the method of Lowry et al. 18 after homogenization in a glass Dounce homogenizer.
Measurements of changes in protein degradation were made by two techniques. In the first procedure, hearts were allowed to stabilize in culture for 18-24 hours and then exposed to [ 3 H]phenylalanine for 4 hours. As described in detail previously, 19 the hearts were then washed at hourly intervals with nonradioactive medium containing excess unlabeled phenylalanine. After three washes, onethird of each litter was harvested for "zero-time" values, one-third was maintained for an additional 24 hours in control medium containing excess nonradioactive phenylalanine to minimize reutilization of label, and one-third was maintained for an identical period in the same medium plus the experimental agent. In some experiments, the final media (both control and experimental) contained cycloheximide, 2.5 /xg/ml, to block protein synthesis and reutilization of label.
For experiments involving chloroquine, initial stabilization for all hearts was in control medium, and experimental hearts were exposed to the drug only during the 24hour degradation period. To test the effects of nonmetabolizable sugars, one group of experiments was performed in which sucrose was present only during the degradation period (i.e., its effects on proteolysis reflected changes during the first day of exposure). In addition, a second group of experiments was performed in which hearts were exposed to sucrose during the 24-hour stabilization, pulsation, and wash period, as well as during the degradation period (i.e., the observed changes in proteolysis reflected differences present during the period spanning the second day of exposure to the agent); for these experiments, two groups of hearts (those exposed to control medium and those exposed to sucrose) were harvested for "zero-time" values, to make allowance for any differences that might be produced in incorporation of label by the prior presence of sucrose. To test for any effects that might be due to the high molarity of the sucrose rather than to its specific effects on lysosomes, similar experiments were made with 100 mM urea, an agent which does not alter lysosomal structure or function significantly. 15 Rates of protein degradation for each group of hearts were calculated from measurements of the amount of radioactivity remaining in trichloroacetic acid (TCA)-precipitable protein after the 24-hour degradation period, as compared to the amount in "zero-time" hearts. 19 Each heart was homogenized in ice-cold 20 mM NaCl-2 mM phosphate buffer (pH 7.4) in a tightly fitting Dounce homogenizer. Protein was precipitated from a sample of each homogenate with cold 10% TCA, collected on a glass filter (Whatman, GF/C) in a funnel precipitation apparatus (ICN Corp.), washed twice with cold TCA, and then solubilized with NCS solubilizer (Amersham/Searle) in a liquid scintillation counting vial. The radioactivity of each sample was measured in a Packard 2425 tricarb scintillation counter in toluene-2,5-diphenyloxazole-l ,4bis[2-(5-phenyloxazolyl)]benzene. In other experiments, changes in net amino acid balance in the hearts were determined, as described previously, 19 by assaying the medium with a Durrum analyzer after 1 or 2 days' cultivation for the net gain or loss of 12 individual amino acids. Because phenylalanine is not synthesized or degraded in heart tissue and is involved only in protein synthesis and breakdown, 20 the rate of uptake or release of total phenylalanine was used as an index of net protein balance (synthesis and degradation) as well as of phenylalanine balance per se. When protein synthesis was blocked with cycloheximide, as described above, measurements of phenylalanine release provided an index of the rate of protein degradation alone. 21
Statistical Analyses
Although results from different litters maintained in organ culture often vary considerably, results from individual hearts within a single litter are highly reproducible (SD < 10%). Accordingly, results from hearts exposed to the experimental agents were compared to matched littermate controls using Student's /-test for paired data. Results are given as the mean ± 1 standard error of the mean for each condition, with n as the number of litters tested.
Results
As reported in previous studies, 17 -l9 ' 21 fetal mouse hearts in organ culture degraded protein at a fairly rapid rate. Thus, as estimated from the loss of radioactive phenylalanine from TCA-precipitable material, 45 ± 3.2% of prelabeled protein was degraded in 24 hours in control hearts (Table 1 ). In contrast, only 32 ± 4.8% of prelabeled protein was degraded during the 24-hour period that hearts of matched littermates were exposed to chloroquine. The difference, which represented a relative retardation in the rate of proteolysis by a factor of almost one-third, was statistically significant (P < 0.01). Experiments in which cycloheximide was present during the degradation period to prevent artifactual differences due to altered reincorporation of label yielded similar results: control hearts degraded protein at a rate of 38 ± 6.5% in the presence of cycloheximide vs. 22 ± 8.2% when chloroquine was added ( Fig. 1 , P < 0.01). When sucrose was added to the medium during the degradation period, the rate of protein breakdown was 40 ± 3.9% vs. 46 ± 1.0% in matched controls (Table 1) . This fairly small difference during the first 24 hours of exposure to the sugar was of only borderline significance statistically (0.05 < P < 0.10). In experiments in which pre-exposure to sucrose for 24 hours had occurred before the hearts were pulsed and degradation rates were measured, the effects of the sugar were much more pronounced. Thus, hearts degraded protein at a rate of 33 ± 3.0%/24 hours during the second day of exposure to sucrose vs. 44 ± 2.5% in littermatched controls tested over the same period ( Table 1 , P < 0.01). In the presence of cycloheximide, the corresponding figures during the second day of sucrose exposure were 26 ± 4.0%/24 hours vs. 39 ± 3.1 %/24 hours in matched controls ( Fig. 2 , P < 0.01). Under identical circumstances, exposure to urea for 2 days caused no changes in the rate of protein degradation (43 ± 4.0%/24 hours in controls vs. 44 ± 4.7%/24hours).
Measurements of the release into the medium of cold phenylalanine during exposure to cycloheximide provided confirmation of the inhibitory effects of chloroquine and sucrose on proteolysis. As shown in Figure 3 , hearts exposed to chloroquine during the first day of culture released phenylalanine at a rate of 0.075 ± 0.0066 mmol/ mg heart weight per hour, as compared to 0.108 ± 0.0057 in litter-matched controls. This 31% decrease was statistically significant (P < 0.01). Sucrose reduced phenylalanine release by 23% during the first 24 hours of cultivation in the presence of cycloheximide (0.083 ± 0.0078 nmol/mg per hour vs. 0.106 ± .0145, P < 0.01). The sugar's effect was much more pronounced during the second 24 hours of exposure, when the rate of phenylalanine release was retarded by 35% (0.060 ± 0.0113 vs. 0.092 ± 0.0132, P < 0.01).
When added to media lacking cycloheximide, so that both synthesis and degradation were active, chloroquine and sucrose tended to improve the net balance (i.e., VOL. 42 reduce the release or increase the uptake) of all the amino acids measured (Tables 2 and 3) .
Discussion
The precise cellular mechanisms by which proteins are broken down to their constituent amino acids are poorly understood. In many tissues, lysosomes appear to play a major role in the process. 22 ' 23 In heart and skeletal muscle, because relatively few lysosomal structures can be identified microscopically, because autophagic vacuoles containing myofibrillar elements are seldom if ever encountered, and because nonlysosomal neutral and alkaline proteinases are abundant, considerable scepticism has remained about whether lysosomes and lysosomal enzymes are of major importance in the degradation of proteins in muscular tissues (see refs. 1, 23, and 24 for reviews).
Direct demonstrations of the quantitative importance of specific lysosomal proteinases have been accomplished for liver, using the specific proteinase inhibitor pepstatin encapsulated in liposomes to facilitate entry into the lysosomal compartment. 25 Similar studies have been diffi-cult in muscle tissues because myocytes do not readily incorporate liposomes or their contents. Furthermore, some other proteinase inhibitors, such as TLCK or leupeptin, which can penetrate cells more easily than pepstatin, may block nonlysosomal as well as lysosomal proteinases and also may produce nonspecific toxic effects which theoretically might alter proteolysis secondarily, independent of their actions on lysosomal enzymes (unpublished observations). Accordingly, in the present experiments we sought to test the effects of agents which, in a variety of tissues including fetal mouse hearts in organ culture, readily gain access to the lysosomal compartment and produce their primary effects on lysosomes with little or no actions in other organelles. 3 " 15 Previous studies on isolated fibroblasts have shown that chloroquine inhibits the lysosomal breakdown of endogenous proteins 10 ' " as well as of certain exogenous proteins that are taken up by endocytosis. 12 -l3 Similarly, our experiments revealed that the breakdown of endogenous cardiac proteins was inhibited by 30% or more during a 24hour exposure to chloroquine.
Exposure to sucrose causes lysosomal derangements in many tissues, including heart. 3 "" 6 -l5 In fetal mouse hearts, the abnormalities can be observed to appear gradually over a period of 1-3 days. 15 In keeping with the rather slow and progressive nature of the development of sucrose-induced lysosomal derangements, changes in protein inhibition also were slow to develop: proteolysis was decreased by only 10-20% during the first day's treatment but by approximately 30% during the second day. It should be pointed out that the degree of inhibition observed, if applicable to both contractile and noncontractile proteins and if sustained in the absence of any change in synthesis, would result in a net accumulation of total protein mass of 10-15% per day over control. At this rate, total cardiac size would tend to double within a week. In other words, this degree of change is very significant, not only statistically but also functionally, when viewed in the context of the development of cardiac hypertrophy. Difference (B -A) -0.095 ± 0.0077* -0.026 ± 0.0047* -0.044 ± 0.0025* -0.055 ± 0.0108* -0.146 ±0.0178* -0.362 ± 0.0374* -0.041 ± 0.0097* -0.030 ± 0.0035* -0.026 ± 0.0032* -0.054 ± 0.0056* -0.039 ± 0.0063* -0.050 ± 0.0066* Results in columns A and B represent the net release (positive numbers) or uptake (negative numbers) of each amino acid (in nmol/mg heart weight per hour) from the heart into the medium during the first day of cultivation; each value represents the mean ± 1 SEM for 24 hearts from eight litters. Column C gives the mean difference ± 1 SEM between the eight matched litters; negative numbers in column C indicate either increased net uptake or reduced net release.
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• P < 0.05 by Student's paired r-test.
With any pharmacological agent that is used to produce selective effects on a single type of organelle or on a single aspect of cellular function, it is probable that other organelles and other functional characteristics will also be altered to some extent. Indeed, this is intrinsically inevitable if the primary disturbance is on an important aspect of cell function, since the complex integration of all the cell's processes will secondarily become upset when a vital link is perturbed. Thus, in the present studies, as in all others in which efforts are made to produce selective perturbations of particular aspects of cell function, one must be concerned whether the final observations represent predominantly the results of the primary perturbation in question or whether secondary, nonspecific toxic effects might not be the cause. Specifically, do the major lysosomal abnormalities known to be produced by sucrose and chloroquine in fetal mouse hearts' 4115 account for the subsequent inhibition of proteolytic capacity observed in the present experiments, or is some other factor more important?
Ultimately, of course, this question can never be answered with certainty. Nevertheless, in the case of sucrose, there is no evidence of apparent abnormalities in any other organelles, l5 cardiac beating (which is an exquisitely sensitive indicator of even mild toxicity or damage in hearts in organ culture) is not depressed over the interval of time observed, 15 and there is a close concurrence of the time-course of the observed effects on lysosomes and on proteolysis. These facts lead one to conclude with some confidence that sucrose-induced inhibition of protein breakdown probably is caused by specific lysosomal dysfunction rather than by nonspecific toxicity. In the case of chloroquine, evidence of some mild, nonspecific toxicity is a bit more disturbing. Although beating remains strong over the first day, exposure to chloroquine leads ultimately to contractile depression (unpublished results). Furthermore, some mitochondrial abnormalities develop after 1-2 days, 1 ' 1 which might lead to inadequate oxidative metabolism. Because interference with normal oxidative metabolism can itself produce inhibition of cardiac prote-olysis, 2126 one must consider the possibility that the observed results might result primarily from mitochondrial damage and inadequate oxidative energy production rather than from lysosomal dysfunction. If toxic damage were severe enough to inhibit oxidative metabolism sufficiently to depress proteolysis, however, alanine production and release from the heart would be expected to increase markedly. 27 Since no such increase occurred ( Table 2) , it seems unlikely that the observed inhibition of proteolysis can be explained by nonspecific cellular toxicity and inadequate oxidative energy production.
In summary, considering all the experiments involved both sucrose and chloroquine, we believe that the most likely explanation of the results is that the observed reductions in protein breakdown are caused primarily by lysosomal derangements. Thus it appears that, in this experimental model, cardiac lysosomes can play a major role in the degradation of myocardial protein and that interference with lysosomal function retards proteolysis.
